|
2025 Conference Publication Optimizing 64Cu production: an efficient approach to 64Ni target material recyclingBarkhausen, Christoph, Stimson, Damion, Najdovski, Ljubco, Poniger, Stan and Thurecht, Kristofer (2025). Optimizing 64Cu production: an efficient approach to 64Ni target material recycling. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109243 |
|
2025 Conference Publication Trifunctional albumin-binding constructs for optimisation of in vivo delivery of cancer radio-theranosticsHe, Xie (Kate), Thurecht, Kristofer, Fletcher, Nicholas, Bell, Craig and Kempe, Kristian (2025). Trifunctional albumin-binding constructs for optimisation of in vivo delivery of cancer radio-theranostics. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109457 |
|
2025 Conference Publication Targeting the oxytocin receptor for breast cancer imaging and radiotherapyMuttenthaler, Markus, Perisic, Monika, Liu, Huiping, Kalaba, Predrag, Madge, Harrison, Dighe, Satish, Fletcher, Nicholas, Migotto, Mary-Anne, Mardon, Karine, Thurecht, Kristofer, Keimpema, Erik and Gruber, Christian (2025). Targeting the oxytocin receptor for breast cancer imaging and radiotherapy. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109302 |
|
2025 Conference Publication D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffoldWood, James, Ghosh, Saikat, Houston, Zachary, Fletcher, Nicholas, Humphries, James, Mardon, Karine, Akhter, Dewan, Tieu, William, Ivashkevich, Alesia, Wheatcroft, Michael, Thurecht, Kristofer and Codd, Rachel (2025). D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffold. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109244 |
|
2025 Conference Publication Pre-targeting of PEG-based nanomedicines: precise delivery of potent payloadsFletcher, Nicholas, Thurecht, Kristofer, Chu, Weijing, Huda, Pie, Humphries, James and Wood, James (2025). Pre-targeting of PEG-based nanomedicines: precise delivery of potent payloads. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109150 |
|
2025 Conference Publication Evaluating mRNA delivery using nuclear medicineHumphries, James, Witjaksono, Andrea, Poudel, Abishek, Mardon, Karine, Migotto, Mary-Anne, Cheetham, Seth, Howard, Christopher and Thurecht, Kristofer (2025). Evaluating mRNA delivery using nuclear medicine. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109117 |
|
2025 Conference Publication Development of novel MnO2-based nanoparticles for PET/MRI-guided Alpha TherapyGulzar, Arif, Wang, Yanan, Balaji, Arunpandian, Fletcher, Nicholas and Thurecht, Kristofer (2025). Development of novel MnO2-based nanoparticles for PET/MRI-guided Alpha Therapy. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD Australia, 11-15 May 2025. Elsevier BV. doi: 10.1016/j.nucmedbio.2025.109532 |
|
2025 Conference Publication Optimising VHH-based radiopharmaceuticals: addressing pharmacokinetics and renal clearance challengesHuda, Pie, Owen, David, Bell, Craig, Wood, James, Humphries, James and Thurecht, Kristofer (2025). Optimising VHH-based radiopharmaceuticals: addressing pharmacokinetics and renal clearance challenges. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109460 |
|
2025 Conference Publication Development of thiosemicarbazonato technetium-99m complexes for SPECT imagingMaclean, Rachel, Fletcher, Nicholas, Alsadig, Ahmed, Chu, Weijing, Sihver, Wiebke, Baraban, Larysa, Thurecht, Kristofer, Kubeil, Manja, Tuck, Kellie and Paterson, Brett (2025). Development of thiosemicarbazonato technetium-99m complexes for SPECT imaging. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109249 |
|
2025 Conference Publication The glycogen synthase kinase-3β inhibitor 9-ING-41 in combination with chemoimmunotherapy provides long-term survival in the Th-MYCN mouse modelMurray, Jayne, Somers, Klaartje, Mak, Crystal, Alfred, Stephanie, Brand, Jennifer, Poon, Evon, Fletcher, Nicholas, Li, Pei, Thurecht, Kristofer, Gray, Juliet, Pearson, Andrew Dj., Chesler, Louis, Hogarty, Michael D., Giles, Francis, Fletcher, Jamie, Ziegler, David S., Norris, Murray D. and Haber, Michelle (2025). The glycogen synthase kinase-3β inhibitor 9-ING-41 in combination with chemoimmunotherapy provides long-term survival in the Th-MYCN mouse model. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1535-7163.TARG-25-B079 |
|
2025 Conference Publication Retrofitting a cyclotron solid target processing system for radiometal production at AIBN, cyclotron and radiochemistry capabilityStimson, Damion, Barkhausen, Christoph, Najdovski, Ljubco, Gulza, Arif, Dixon, Carl, Maillet, Donald and Thurecht, Kristofer (2025). Retrofitting a cyclotron solid target processing system for radiometal production at AIBN, cyclotron and radiochemistry capability. ANZSNM ASM 2025, Melbourne, VIC Australia, 23-25 May 2025. Hoboken, NJ, United States: Wiley. doi: 10.1111/imj.70120 |
|
2024 Conference Publication Dendrimer nanoparticles (DEP) enable targeted precision delivery and customized biodistribution for cancer radiotheranosticsCastellarnau, Alex, Heery, Graham, Kelly, Brian, Yong, Ken, Paull, Jeremy, Thurecht, Kristofer, Humphries, James, Akhter, Dewan, Giannis, Michael and Hufton, Richard (2024). Dendrimer nanoparticles (DEP) enable targeted precision delivery and customized biodistribution for cancer radiotheranostics. 2024 SNMMI Annual Meeting, Toronto, Canada, 8-11 June 2024. Reston, VA USA: Society of Nuclear Medicine. |
|
2023 Conference Publication A HER2 targeted polylysine dendrimer nanoparticle radiotheranostic demonstrates excellent tumor accumulation, rapid clearance from circulation, and promising performance in PET-CT imagingJohnstone, Cameron N., Heery, Graham P., Kelly, Brian D, Humphries, James, Akhter, Dewan T., Thurecht, Kristofer J., Yuen, Daniel, Giannis, Michael, Yong, Ken, Chadwick, Gareth, Barker, Helena, Cargill, Anne, Eglezos, Anthony, Castellarnau, Alex, Paull, Jeremy R. A. and Hufton, Richard (2023). A HER2 targeted polylysine dendrimer nanoparticle radiotheranostic demonstrates excellent tumor accumulation, rapid clearance from circulation, and promising performance in PET-CT imaging. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, MA United States, 11-15 October 2023. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1535-7163.targ-23-a147 |
|
2023 Conference Publication Dox- loaded mpeg nanoparticles as a promising treatment in a humanized mouse model for breast cancer bone metastasisFrankenbach, Tina, Landgraf, Marietta, Fletcher, Nicholas, Howard, Christopher, Ravichandran, Akhilandeshwari, Akhter, Dewan, Shafiee, Abbas, Holzapfel, Boris M., Thurecht, Kristofer, McGovern, Jacqui and Hutmacher, Dietmar W. (2023). Dox- loaded mpeg nanoparticles as a promising treatment in a humanized mouse model for breast cancer bone metastasis. Tissue Engineering and Regenerative Medicine International Society (TERMIS), Krakow, Poland, 28 June - 1 July 2022. New Rochelle, NY United States: Mary Ann Liebert. |
|
2022 Conference Publication Immuno-PET agents for targeting glioblastomaGhosh, S., Huda, P., Fletcher, N., Howard, C., Lu, Y., Campbell, D., Walsh, B. and Thurecht, K. (2022). Immuno-PET agents for targeting glioblastoma. Australian and New Zealand Society of Nuclear Medicine (ANZSNM) 52nd ASM, Brisbane, QLD, Australia, 13–15 May 2022. Richmond, VIC, Australia: John Wiley & Sons. |
|
2020 Conference Publication Canine PET/CT imaging with 64Cu-nanomedicinesDaniel, Sarah, Houston, Zachary, Fletcher, Nicholas, Bell, Craig, Atcheson, Nicole, Al-Najjar, Aiman, Howard, Christopher, Mahler, Stephen, Straw, Rod and Thurecht, Kristofer (2020). Canine PET/CT imaging with 64Cu-nanomedicines. SNMMI Annual Meeting, Online, 11-14 July, 2020. Reston, VA, United States: Society of Nuclear Medicine. |
|
2019 Conference Publication Innovation in diagnosis and treatment of brain metastases using multifunctional nanomedicinesSaunus, J. M., Lim, M., Puttick, S., Croft, P. Kalita-de, Houston, Z. H., Jones, M. L., Latter, M. J., Campbell, L. C., Thomas, P., Jeffree, R. L., Rose, S. E., Mahler, S. M., Thurecht, K. J., Scott, A. M. and Lakhani, S. R. (2019). Innovation in diagnosis and treatment of brain metastases using multifunctional nanomedicines. San Antonio Breast Cancer Symposium, San Antonio, Texas, 4-8 December 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-P1-19-02 |
|
2018 Conference Publication Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1)Yeh, Mei-Chun, Tse, Brian W. C., Fletcher, Nicholas L., Huston, Zachary H., Stewart, Chelsea, Sokolowski, Kamil, Jeet, Varinder, Wissmueller, Sandra, Thurecht, Kristofer J., Campbell, Douglas H., Walsh, Bradley J., Nelson, Colleen C. and Russell, Pamela J. (2018). Targeted beta therapy of human prostate cancer in vivo with Lu-177 labelled MIL-38 antibody against glypican-1 (GPC-1). 19th Asia-Pacific Prostate Cancer Conference, Brisbane Australia, Aug 22-25, 2018. HOBOKEN: WILEY. |
|
2018 Conference Publication EPHA3 a novel tumour specific therapeutic target for medulloblastomaOffenhauser, Carolin, Carrington, Benjamin, Thurecht, Kris, Ensbey, Kathleen, Bruce, Zara, Jamieson, Paul, Lim, Yi Chieh, Akgul, Seckin, Li, Michelle, Stringer, Brett, Puttick, Simon, Fuchs, Adrian, Picard, Daniel, Ingram, Wendy, Hallahan, Andrew, Moore, Andrew, Johns, Terrance, Gottardo, Nicholas, Remke, Marc, Boyd, Andrew and Day, Bryan (2018). EPHA3 a novel tumour specific therapeutic target for medulloblastoma. 18th International Symposium on Pediatric Neuro-Oncology (ISPNO), Denver, CO USA, 30 June-3 July 2018. Cary, NC USA: Oxford University Press. |
|
2018 Conference Publication Development of polymer theranostics to probe the behaviour of nanomaterials in biologyThurecht, Kristofer, Zhou, Yongmei, Fletcher, Nicholas and Houston, Zachary (2018). Development of polymer theranostics to probe the behaviour of nanomaterials in biology. 255th National Meeting and Exposition of the American-Chemical-Society (ACS) - Nexus of Food, Energy, and Water, New Orleans, LA United States, 18-22 March 2018. Washington, DC United States: American Chemical Society. |
